Alnair Therapeutics

Alnair Therapeutics

Pre-clinical
Cambridge, United StatesFounded 2020alnairbio.com

Tumors rely on aerobic glycolysis where they consume large amounts of glucose and convert it directly into lactate, even when oxygen is available. This process known as the Warburg Effect fuels rapid cell division and results in a high concentration of lactate being secreted, which becomes even higher in aggressive tumors.

Founded
2020
Focus
Drug Delivery

About

Tumors rely on aerobic glycolysis where they consume large amounts of glucose and convert it directly into lactate, even when oxygen is available. This process known as the Warburg Effect fuels rapid cell division and results in a high concentration of lactate being secreted, which becomes even higher in aggressive tumors.

Funding History

1

Total raised: $5M

Seed$5MUndisclosedJun 15, 2022

Company Info

TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile